πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 6 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11642335

Chemical synthesis of clopidogrel active metabolites and disulfide conjugate prodrugs

The Board of Regents of the University of Texas System Β· Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9889125

Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopi

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9233103

Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopi

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7259261

Racemization and enantiomer separation of clopidogrel

TEVA GyΓ³gyszergyΓ‘r ZΓ‘rtkΓΆrΓΌen MΓΌkΓΆdΓΆ RΓ©szvΓ©nytΓ‘rasasΓ‘g Β· Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 6800759

Racemization and enantiomer separation of clopidogrel

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Oct 05 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6737411

Racemization and enantiomer separation of clopidogrel

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired